Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MDMA and serotonin: based on two cases.

I Garcia Cabeza1, A Zabala, M L Soto-Montenegro

  • 1Hospital General Universitario Gregorio Marañón, Servicio de Psiquiatría I, Ibiza 43, 28009 Madrid, Spain.

Actas Espanolas De Psiquiatria
|September 13, 2005
PubMed
Summary

3,4-methylenedioxyamphetamine (MDMA) damages serotonin neurons in humans, leading to psychopathological and cognitive issues. This research highlights the need for careful diagnosis and treatment of these MDMA-related disturbances.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-coding Regulatory Variants in ASD (Autism Spectrum Disorders) Disrupt CTCF Domains and Shape Cell-Type-Specific Neurodevelopmental Landscapes Revealed by Single-Cell Analyses and Cortical Organoids.

Research square·2026
Same author

Efficacy, safety, and tolerability of arbaclofen in Autistic children and adolescents, the AIMS-2-TRIALS-CT1: a randomized, double-blind, placebo-controlled phase II trial.

EClinicalMedicine·2026
Same author

Alternative splicing analysis in a Spanish ASD (Autism Spectrum Disorders) cohort: in silico prediction and characterization.

Scientific reports·2025
Same author

Cannabis use and cognitive biases in people with first-episode psychosis and their siblings.

Psychological medicine·2024
Same author

Turning of 42CrMo4+QT under different scenarios: Dataset of machining, roughness and residual stress.

Data in brief·2024
Same author

Large-scale analysis of structural brain asymmetries during neurodevelopment: Associations with age and sex in 4265 children and adolescents.

Human brain mapping·2024

Area of Science:

  • Neuroscience
  • Psychiatry
  • Toxicology

Background:

  • 3,4-methylenedioxyamphetamine (MDMA), commonly known as "ecstasy," is increasingly used by young populations.
  • Animal studies consistently show MDMA neurotoxicity, specifically damage to serotonin neurons.
  • Emerging evidence suggests similar neurotoxic effects in humans.

Observation:

  • Two clinical cases are presented detailing psychopathological and cognitive symptoms in MDMA users.
  • These symptoms support the hypothesis of MDMA-induced neurotoxicity in humans.
  • Difficulties in diagnosing psychiatric disorders associated with MDMA use are noted.

Findings:

  • MDMA use is linked to significant psychopathological and cognitive disturbances.
  • Serotonin neuron damage is a likely mechanism underlying these observed symptoms.

Related Experiment Videos

  • The findings underscore the potential long-term neurological impact of recreational MDMA use.

    • Implications:

    • Clinical diagnosis of psychiatric disorders in MDMA users requires careful consideration of neurotoxicity.
    • Therapeutic strategies must address both psychiatric symptoms and potential underlying neurological damage.
    • Increased awareness and research are needed regarding the long-term cognitive and psychiatric consequences of MDMA consumption.